nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse effects might predict response in breast cancer
|
Sharma, Sharan Prakash |
|
2013 |
14 |
7 |
p. e258- 1 p. |
artikel |
2 |
Asbestos is not just asbestos: an unrecognised health hazard
|
Baumann, Francine |
|
2013 |
14 |
7 |
p. 576-578 3 p. |
artikel |
3 |
A selective ALK inhibitor in ALK-rearranged patients
|
Yang, James Chih-Hsin |
|
2013 |
14 |
7 |
p. 564-565 2 p. |
artikel |
4 |
Aurora kinase B inhibitor benefits elderly patients with AML
|
Sharma, Sharan Prakash |
|
2013 |
14 |
7 |
p. e255- 1 p. |
artikel |
5 |
Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer
|
Fayda, Merdan |
|
2013 |
14 |
7 |
p. e250- 1 p. |
artikel |
6 |
Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer
|
Boyages, John |
|
2013 |
14 |
7 |
p. e250-e251 nvt p. |
artikel |
7 |
Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer – Authors' reply
|
Galimberti, Viviana |
|
2013 |
14 |
7 |
p. e251-e252 nvt p. |
artikel |
8 |
Bevacizumab is linked to cases of necrotising fasciitis
|
Wong, Jennifer |
|
2013 |
14 |
7 |
p. e259- 1 p. |
artikel |
9 |
Cancer apps
|
Burki, Talha Khan |
|
2013 |
14 |
7 |
p. 580-581 2 p. |
artikel |
10 |
Cancer stem cells—therapeutic targeting or therapy?
|
Filipovic, Aleksandra |
|
2013 |
14 |
7 |
p. 579-580 2 p. |
artikel |
11 |
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial
|
Crosby, Thomas |
|
2013 |
14 |
7 |
p. 627-637 11 p. |
artikel |
12 |
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study
|
Seto, Takashi |
|
2013 |
14 |
7 |
p. 590-598 9 p. |
artikel |
13 |
Contralateral risk-reducing mastectomy in sporadic breast cancer
|
Murphy, John A |
|
2013 |
14 |
7 |
p. e262-e269 nvt p. |
artikel |
14 |
Correction to Lancet Oncol 2013; 14: 557
|
|
|
2013 |
14 |
7 |
p. e254- 1 p. |
artikel |
15 |
Correction to Lancet Oncol 2013; 14: 297
|
|
|
2013 |
14 |
7 |
p. e254- 1 p. |
artikel |
16 |
Correction to Lancet Oncol 2013; 14: 481
|
|
|
2013 |
14 |
7 |
p. e254- 1 p. |
artikel |
17 |
Cosmetic implants could delay breast cancer diagnosis
|
Burki, Talha Khan |
|
2013 |
14 |
7 |
p. e260- 1 p. |
artikel |
18 |
Effects of a programme of interventions on regional comprehensive palliative care for patients with cancer: a mixed-methods study
|
Morita, Tatsuya |
|
2013 |
14 |
7 |
p. 638-646 9 p. |
artikel |
19 |
Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial
|
Amadori, Dino |
|
2013 |
14 |
7 |
p. 663-670 8 p. |
artikel |
20 |
Evolution of prostate cancer gene mutations
|
Burki, Talha Khan |
|
2013 |
14 |
7 |
p. e257- 1 p. |
artikel |
21 |
Extending the case for oestradiol in androgen-sensitive prostate cancer
|
Wassersug, Richard J |
|
2013 |
14 |
7 |
p. e252-e253 nvt p. |
artikel |
22 |
Extending the case for oestradiol in androgen-sensitive prostate cancer – Authors' reply
|
Langley, Ruth |
|
2013 |
14 |
7 |
p. e253- 1 p. |
artikel |
23 |
Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial
|
Jin, Jie |
|
2013 |
14 |
7 |
p. 599-608 10 p. |
artikel |
24 |
Image-guided brachytherapy effective for cervical cancer
|
Tanday, Sanjay |
|
2013 |
14 |
7 |
p. e256- 1 p. |
artikel |
25 |
Imatinib is exorbitantly priced despite protests
|
Wong, Jennifer |
|
2013 |
14 |
7 |
p. e258- 1 p. |
artikel |
26 |
Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study
|
Ciatto, Stefano |
|
2013 |
14 |
7 |
p. 583-589 7 p. |
artikel |
27 |
Integration of general oncology and palliative care
|
Kaasa, Stein |
|
2013 |
14 |
7 |
p. 571-572 2 p. |
artikel |
28 |
Is there a standard induction regimen for patients with AML?
|
Ravandi, Farhad |
|
2013 |
14 |
7 |
p. 565-566 2 p. |
artikel |
29 |
It's time to quit
|
The Editors, |
|
2013 |
14 |
7 |
p. 578- 1 p. |
artikel |
30 |
Molecular mutations in atypical chronic leukaemia
|
Burki, Talha Khan |
|
2013 |
14 |
7 |
p. e261- 1 p. |
artikel |
31 |
New combination treatment for anaplastic thyroid cancer
|
Sharma, Sharan Prakash |
|
2013 |
14 |
7 |
p. e256- 1 p. |
artikel |
32 |
No fall in mammogram rates after USPSTF recommendations
|
Marshall, Hilary |
|
2013 |
14 |
7 |
p. e255- 1 p. |
artikel |
33 |
Pale Girl Speaks
|
Penny, Helen |
|
2013 |
14 |
7 |
p. 582- 1 p. |
artikel |
34 |
Pancreaticoduodenectomy: time to change our approach?
|
Wolfgang, Christopher L |
|
2013 |
14 |
7 |
p. 573-575 3 p. |
artikel |
35 |
Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy for pancreatic or periampullary tumours: a multicentre randomised trial
|
Topal, Baki |
|
2013 |
14 |
7 |
p. 655-662 8 p. |
artikel |
36 |
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial
|
Arits, Aimée HMM |
|
2013 |
14 |
7 |
p. 647-654 8 p. |
artikel |
37 |
Platelet prophylaxis for haematological cancers
|
Baker, Holly |
|
2013 |
14 |
7 |
p. e261- 1 p. |
artikel |
38 |
Potential drug targets in acute myeloid leukaemia
|
Benmaamar, Ramla |
|
2013 |
14 |
7 |
p. e259- 1 p. |
artikel |
39 |
Prognosis of breast cancer during pregnancy
|
Baker, Holly |
|
2013 |
14 |
7 |
p. e257- 1 p. |
artikel |
40 |
Reproductive organ involvement in non-Hodgkin lymphoma during pregnancy: a systematic review
|
Horowitz, Netanel A |
|
2013 |
14 |
7 |
p. e275-e282 nvt p. |
artikel |
41 |
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
|
Kuehn, Thorsten |
|
2013 |
14 |
7 |
p. 609-618 10 p. |
artikel |
42 |
Sentinel node biopsy and neoadjuvant chemotherapy
|
Cody III, Hiram S |
|
2013 |
14 |
7 |
p. 567-568 2 p. |
artikel |
43 |
Speculation overinflates long-term efficacy of vaccine for anal dysplasia
|
Talboy, Glenn E |
|
2013 |
14 |
7 |
p. e249-e250 nvt p. |
artikel |
44 |
Surrogate endpoints: can size of effect mitigate perplexity?
|
Perrone, Francesco |
|
2013 |
14 |
7 |
p. 568-569 2 p. |
artikel |
45 |
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data
|
Mauguen, Audrey |
|
2013 |
14 |
7 |
p. 619-626 8 p. |
artikel |
46 |
Targeted therapy and chemoradiotherapy in oesophageal cancer
|
Burmeister, Bryan H |
|
2013 |
14 |
7 |
p. 569-570 2 p. |
artikel |
47 |
The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached?
|
Abou-Alfa, Ghassan K |
|
2013 |
14 |
7 |
p. e283-e288 nvt p. |
artikel |
48 |
The Fault in Our Stars
|
O'Donoghue, Odhran |
|
2013 |
14 |
7 |
p. 581-582 2 p. |
artikel |
49 |
Treating basal-cell carcinoma in a real life setting
|
Dummer, Reinhard |
|
2013 |
14 |
7 |
p. 572-573 2 p. |
artikel |
50 |
Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy?
|
Senan, Suresh |
|
2013 |
14 |
7 |
p. e270-e274 nvt p. |
artikel |
51 |
Two or three doses of human papillomavirus vaccine?
|
Baker, Holly |
|
2013 |
14 |
7 |
p. e260- 1 p. |
artikel |
52 |
UK Government panders to tobacco industry and lacks social conscience
|
The Lancet Oncology, |
|
2013 |
14 |
7 |
p. 563- 1 p. |
artikel |
53 |
Zooming in on the schedule of bone-modifying drugs
|
Martin, Miguel |
|
2013 |
14 |
7 |
p. 575-576 2 p. |
artikel |